Equities
Health CarePharmaceuticals and Biotechnology
  • Price (USD)1.00
  • Today's Change0.00 / 0.00%
  • Shares traded200.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 03 2024 19:37 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue4,5173,9513,224
OPERATING EXPENSES
Cost of revenue total1,1221,012813
Selling, general and admin. expenses, total2,3142,1071,763
Depreciation/amortization------
Unusual expense(income)2.39(0.13)16
Other operating expenses, total(163)(113)(102)
Total operating expense3,2743,0332,502
Operating income1,243918721
Other, net------
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes1,240917720
Provision for income taxes271194163
Net income after taxes970723557
Minority interest------
Net income before extra. Items970723557
Total extraordinary items------
Net income970723557
Inc.avail. to common excl. extra. Items970723557
Inc.avail. to common incl. extra. Items970723557
EPS RECONCILIATION
Basic/primary weighted average shares755755755
Basic/primary eps excl. extra items1.280.960.74
Basic/primary eps incl. extra items1.280.960.74
Dilution adjustment------
Diluted weighted average shares755755755
Diluted eps excl. extra items1.280.960.74
Diluted eps incl. extra items1.280.960.74
COMMON STOCK DIVIDENDS
DPS - common stock primary issue0.430.340.38
Gross dividend - common stock8383453
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental2.740.631.25
SUPPLEMENTAL INCOME
Depreciation, supplemental163167167
Total special items2.39(0.19)16
NORMALISED INCOME
Normalized income before taxes1,243917737
Effect of special items on income taxes0.52(0.04)3.74
Income tax excluding impact of special items271194167
Normalized income after tax971723569
Normalized income avail. to common971723569
Basic normalized EPS1.290.960.75
Diluted normalized EPS1.290.960.75
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.